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Abstract
Background:  The recombinant antigen BmR1 has been extensively employed in both ELISA and
immunochromatographic rapid dipstick (Brugia Rapid) formats for the specific and sensitive detection of IgG4 antibodies
against the lymphatic filarial parasites Brugia malayi and Brugia timori. In sera of individuals infected with Wuchereria
bancrofti the IgG4 reactivity to BmR1 is variable, and cross-reactivity of sera from individuals infected with Onchocerca
volvulus or Loa loa was observed only in single cases. In order to characterize the homologs of the BmR1 antigen in W.
bancrofti (Wb-BmR1), O. volvulus (Ov-BmR1) and L. loa (Ll-BmR1) the cDNA sequences were identified, the protein
expressed and the antibody reactivity of patients' sera was studied.
Methods: PCR methodology was used to identify the cDNA sequences from cDNA libraries and/or genomic DNA of
W. bancrofti, O. volvulus and L. loa. The clones obtained were sequenced and compared to the cDNA sequence of BmR1.
Ov-BmR1 and Ll-BmR1 were expressed in E. coli and tested using an IgG4-ELISA with 262 serum samples from individuals
with or without B. malayi, W. bancrofti, O. volvulus and L. loa infections or various other parasitic infections. BmR1, Ov-
BmR1 and Ll-BmR1 were also tested for reactivity with the other three IgG subclasses in patients' sera.
Results: Wb-BmR1 was found to be identical to BmR1. Ov-BmR1 and Ll-BmR1 were found to be identical to each other
and share 99.7% homology with BmR1. The pattern of IgG4 recognition of all serum samples to BmR1, Ov-BmR1 and Ll-
BmR1 were identical. This included weak IgG4 reactivities demonstrated by L. loa- and O. volvulus-infected patients tested
with Ov-BmR1 and Ll-BmR1 (or BmR1). With respect to reactivity to other IgG subclasses, sera from O. volvulus- and L.
loa-infected patients showed positive reactions (when tested with BmR1, Ov-BmR1 or Ll-BmR1 antigens) only with IgG1.
No reactivity was observed with IgG2 or with IgG3. Similarly, ELISAs to detect reactivity to other anti-filarial IgG
subclasses antibodies showed that sera from individuals infected with B. malayi or W. bancrofti (active infections as well
as patients with chronic disease) were positive with BmR1 only for IgG1 and were negative when tested with IgG2 and
with IgG3 subclasses.
Conclusions: This study demonstrates that homologs of the BmR1 antigen are present in W. bancrofti, O. volvulus and L.
loa and that these antigens are highly conserved. Recognition of this antigen by patients' sera is similar with regard to
IgG1, IgG2 and IgG3, but different for IgG4 antibodies. We conclude that the BmR1 antigen is suitable for detection of
IgG4 antibodies in brugian filariasis. However, its homologs are not suitable for IgG4-based diagnosis of other filarial
infections.
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Background
Lymphatic filariasis (LF) caused by Brugia malayi and Bru-
gia timori is endemic in several Asian countries and infects
approximately 13 million people. In May 2000, The Glo-
bal Program for Elimination of Lymphatic Filariasis
(GPELF http://www.filariasis.org/) was officially formed
with the goal of eliminating the disease as a public health
problem by the year 2020. To this end, sensitive and spe-
cific field-applicable diagnostic tools are required for
mapping the distribution of the disease and monitoring
the various phases of the program. Many areas endemic
for LF are remote and have poor access to well-equipped
laboratories, thus a rapid and field-applicable diagnostic
test is important to ensure that it can be easily be per-
formed by field workers and reliable, reproducible, results
can be obtained. For bancroftian filariasis caused by
Wuchereria bancrofti, the ICT antigen card test (Binax Inc.,
USA http://www.binax.com/) is widely used for this pur-
pose. This test is based on the detection of a circulating
adult worm antigen of W. bancrofti. Although this antigen
is also present in Brugia [1], a reliable antigen detection
test for human B. malayi infection is not available. There-
fore, despite its inconvenience and insensitivity, routine
diagnosis of brugian filariasis is made by light microscopy
of night blood.
Although PCR assays are highly sensitive, these mainly
detect individuals with circulating microfilariae (mf); and
they are both time consuming and labour-intensive
requiring well-equipped laboratory facilities.
Detection of anti-filarial IgG4 antibody provides a good
alternative diagnostic tool for brugian filariasis, as this
antibody subclass has been shown to be elevated in active
infection and decline post-treatment [2-9]. Recombinant
antigen-based antibody assays would be preferable over
assays based on parasite extracts since the former allow for
unlimited supply of well-defined antigens.
The  BmR1 recombinant antigen, expressed by gene
pPROEXHT/Bm17DIII  (GenBank accession no.
AF225296), has been shown by us to be a highly specific
and sensitive antigen for IgG4 assays to detect exposure to
both B. malayi and B. timori infections. The antigen has
been used in both ELISA and immunochromatographic
rapid dipstick (Brugia Rapid) formats, and evaluation in
various laboratories and field trials has revealed a sensitiv-
ity of 93%–100% in detecting microfilariaemic individu-
als [9-13]. Furthermore, in some endemic areas
antibodies were also detected in amicrofilaraemic individ-
uals, indicating the sensitivity of the assay in detecting
sub-patent infections in brugian filariasis [10,13-15]. The
BmR1 antigen is highly specific (99%–100%) with respect
to reactivity with sera from non-filarial infections [11,12].
The highest prevalence of cross-reacting antibodies in
other filarial infections was found in W. bancrofti, fol-
lowed by Loa loa, while only one sample of nine patients
with Dirofilaria  infection was found to be reactive. No
cross-reactivity was exhibited in patients infected with O.
volvulus or Mansonella [11,16].
Due to its diagnostic significance, it is therefore important
to characterize the BmR1 antigen more closely. The vary-
ing degree of BmR1 recognition in other filarial infection
raises the question of whether the homologous antigen is
also present in W. bancrofti, L. loa and O. volvulus. In the
present study we have shown that BmR1 antigen is highly
conserved (99–100% amino acid identity), and that
almost identical antigens are present in the other human
filarial parasites of public health importance. Interest-
ingly, however, the ability of the hosts to mount IgG4
response to BmR1 homologs was found to be highly vari-
able in some infections. In addition, the antibody
responses of other IgG subclasses to BmR1 and its
homolog were also investigated.
Materials & methods
cDNA and genomic DNA
W. bancrofti microfilaria (mf), adult male and adult
female cDNA libraries were obtained from the Filarial
Genome Project Resource Centre (Smith College, North-
ampton, Massachusetts, USA genome@smith.edu).
Genomic DNA of W. bancrofti mf were prepared from
samples provided by Dr. B Ravindran, Division of Immu-
nology, Regional Medical Research Centre, Indian Coun-
cil of Medical Research, Bhubaneswar, India http://
icmr.nic.in/. The samples were comprised of two from
individuals whose serum/blood samples were negative by
the Brugia Rapid test and two from individuals who were
positive by the Brugia Rapid test. L. loa L3 and O. volvulus
mf cDNA libraries were kindly provided by Dr. P Fischer,
Bernhard Nocht Institute for Tropical Medicine, Ham-
burg, Germany http://www.bni.uni-hamburg.de/.
PCR
To amplify the entire Bm17DIII gene sequence the follow-
ing PCR primers were used: RNF (24 mer) 5' ATT ACT GAT
TAG TAT TTT ATC GTT 3' and RNR (24 mer) 5'ATG ATA
AAA ATG AAT GAG AAA TAT 3'. λ phage plaques were
amplified and the DNA was extracted using a λ DNA
extraction kit (Qiagen, Germany http://www.qiagen.com/
). PCR was then performed in a thermocycler (Perkin
Elmer, USA http://www.perkinelmer.com/) at the follow-
ing conditions: 94°C, 5 mins.; 55°C, 5 mins.; 35 cycles for
94°C, 45 sec; 55°C, 45 sec & 72°C, 90 sec; 72°C, 10 mins.
Genomic DNA from W. bancrofti mf was prepared using
Genispin Tissue DNA Kit (BioSynTech, Malaysia http://
www.biosyntech.com/). PCR amplifications using the
above primers were then performed using the followingFilaria Journal 2004, 3:10 http://www.filariajournal.com/content/3/1/10
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thermocycler conditions: 94°C, 5 mins; 35 cycles for
94°C, 1 min; 55°C, 1 min & 72°C, 1 min; 72°C, 10 mins.
TOPO cloning and DNA sequence analysis
For sequence analysis of the gene homologs in W. ban-
crofti, O. volvulus and L. loa, the PCR products were cloned
into TOPO-TA vector (Invitrogen, USA http://www.invit
rogen.com/), then transformed into E. coli TOP10 host
(Invitrogen, USA http://www.invitrogen.com/). The
recombinant plasmids were then amplified, purified
using QIAprep®  Spin Miniprep Kit (Qiagen, Germany
http://www.qiagen.com/), and subsequently sent for
sequencing (ACGT Inc, USA http://www.acgtinc.com/).
The results of the DNA sequences were analyzed using
vector NTI software (Invitrogen, USA http://www.invitro
gen.com/).
Subcloning, expression and purification of Ov17DIII/
Ll17DIII
The Bm17DIII gene homologs in O. volvulus and L. loa
were subcloned into a bacterial expression vector,
pPROEX-HT which contain 6-His tag (Life Technologies,
USA http://www.invitrogen.com/), then transformed into
E. coli TOP 10 host cells.
The recombinant bacteria were cultured in Terrific broth
and placed in a shaker incubator at 37°C until the optical
density reached 0.5. The culture was then induced with 1
mM IPTG (isopropyl β-D-thiogalactopyranoside) for 3 hrs
at 30°C. The bacterial pellet was reconstituted with lysis
buffer containing 50 mM Tris HCl (pH 8.5), 5 mM 2-mer-
captoethanol and a cocktail of protease inhibitors (Roche
Diagnostics, Germany http://www.roche-diagnos
tics.com/). The suspension was sonicated at 200 W for 10
minutes, followed by centrifugation at 12 000 g for 30
minutes. The resulting supernatant was purified using Ni-
NTA resin (Qiagen, Germany http://www.qiagen.com/)
and buffers containing imidazole. The protein-containing
fractions were then pooled.
ELISA
The methodology employed was as previously reported
[9]. Briefly, microtiter wells (Nunc, USA http://www.nal
genunc.com/) were coated with 100 µl of either BmR1 (20
µg/ml) or the homologous recombinant antigens (5, 10
or 20 µg/ml) in NaHCO3 buffer (pH 9.6). After a blocking
step, serum samples (1:20 or 1:50 or 1:100) were incu-
bated for 2 h, followed by 0.5 h incubation with the sec-
ondary antibody HRP conjugated to monoclonal anti-
human IgG1 (1:6000), IgG2 (1:1000, 1:2000), IgG3
(1:1000, 1:2000) or IgG4 (1:4500) (CLB Sanquin Blood
Supply Foundation, Netherlands http://www.sanquin.nl/
). Subsequently ABTS substrate (Roche Diagnostics, http:/
/www.roche-diagnostics.com/) was added for 30 minutes
before the optical densities (OD) were read at 410 nm
with an ELISA spectrophotometer (Dynatech (now
DYNEX Technologies), USA http://www.dynextechnolo
gies.com/).
Serum samples were from existing serum banks, collected
according to the ethical requirements of each institution.
The samples were as follows: O. volvulus, L. loa, W. ban-
crofti, B. malayi and other parasitic infections. In addition
serum samples from endemic normals (healthy and Bru-
gia Rapid negative individuals from endemic areas in
Malaysia) and non-endemic normals (healthy blood
donors from Malaysia) were also tested. The O. volvulus
sera were from microfilaremic from western Uganda [17].
L. loa sera were from microfilaremic individuals from the
clinical department of the Bernhard Nocht Institute for
Tropical Medicine, Hamburg, Germany. W. bancrofti sera
samples were from India; while sera from B. malayi infec-
tions, endemic normals, non-endemic normals and other
parasitic infections were from Malaysia. Infections with
other parasites comprised of patients from Malaysia:
• whose stool specimens were positive for parasite ova/
larva (single or mixed infections with Ascaris lumbricoides,
Trichuris trichiura, hookworm, Strongyloides stercoralis)
• with clinical presentation and serology consistent with
toxocariasis and amoebiasis
• with Gnathostoma spinigerum isolated from the eye (one
patient)
Results
Identification of the BmR1 homolog in W. bancrofti, O. 
volvulus and L. loa
In order to explain the pattern of antigen recognition in
patients with other filarial infection we identified the
homologs of the BmR1 antigen in W. bancrofti (Wb-
BmR1), O. volvulus (Ov-BmR1) and L. loa (LI-BmR1). PCR
of W. bancrofti cDNA libraries and W. bancrofti genomic
DNA (from all 4 mf samples) produced a single band of
618 bp. PCR products were eluted from band 618 and
cloned into TOPO vector. A total of 12 recombinant
clones from six TOPO reactions (2 from mf cDNA, 1 from
adult female cDNA, 1 from adult male cDNA and 2 from
mf genomic DNA) were sequenced. A total of 31 DNA
sequencing reactions were analyzed and all obtained
sequences were identical. Comparison of the obtained
nucleotide sequence showed that it was identical to cDNA
sequence of BmR1, irrespective whether the template DNA
came from cDNA libraries, or microfilaria originated from
individuals positive or negative for Brugia Rapid.
For identification of the cDNA of the Ov-BmR1 and Ll-
BmR1, a total of 5 and 3 recombinant clones were
sequenced, respectively (comprising a total of 20Filaria Journal 2004, 3:10 http://www.filariajournal.com/content/3/1/10
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a) Nucleotide sequence of Bm17DIII and its homologs in W. bancrofti, O. volvulus and L. loa Figure 1
a) Nucleotide sequence of Bm17DIII and its homologs in W. bancrofti, O. volvulus and L. loa. Top sequence data 
shows DNA sequences of Bm17DIII and its homologs in W. bancrofti, O. volvulus and L. loa. b) Amino acid sequence of 
BmR1 and its homologs in W. bancrofti, O. volvulus and L. loa. Bottom sequence data shows amino acid sequence of 
BmR1 and its homologs in W. bancrofti (Wb-BmR1), O. volulus (Ov-BmR1) and L. loa (Ll-BmR1). Comparison between Bm17DIII 
DNA sequence and its DNA homologs in O. volvulus and L. loa showed only two bases difference at 98 and 483. BmR1 
homologs of the amino acid sequence was identical with W. bancrofti. However, with O. volvulus and L. loa a difference occurred 
only at one amino acid coded by bases 97–99 i.e. a change from Ile (ATC) to Thr (ACC).
 A                    1                                                50 
   » Bm17DIII    (1) ATGATAAAAATGAATGAGAAATATGTTAAAGAATTGATACTACTGCTGTT
   » Wb17DIII    (1) ATGATAAAAATGAATGAGAAATATGTTAAAGAATTGATACTACTGCTGTT 
   » Ov17DIII    (1) ATGATAAAAATGAATGAGAAATATGTTAAAGAATTGATACTACTGCTGTT 
   » Ll17DIII    (1) ATGATAAAAATGAATGAGAAATATGTTAAAGAATTGATACTACTGCTGTT
     Contig 1    (1) ATGATAAAAATGAATGAGAAATATGTTAAAGAATTGATACTACTGCTGTT 
                    51                                               100 
   » Bm17DIII   (50) GTTCGCTATGATATATACATCGTTAGAGTCGAATTGTGAATTTTGGATCG
   » Wb17DIII   (50) GTTCGCTATGATATATACATCGTTAGAGTCGAATTGTGAATTTTGGATCG
   » Ov17DIII   (50) GTTCGCTATGATATATACATCGTTAGAGTCGAATTGTGAATTTTGGACCG
   » Ll17DIII   (50) GTTCGCTATGATATATACATCGTTAGAGTCGAATTGTGAATTTTGGACCG
     Contig 1   (50) GTTCGCTATGATATATACATCGTTAGAGTCGAATTGTGAATTTTGGAYCG 
                    101                                              150 
   » Bm17DIII  (100) AAGATGATTTTCATCCATTTGTGCCAAAATCAGAGGAAGCACGAGAAGAA 
   » Wb17DIII  (100) AAGATGATTTTCATCCATTTGTGCCAAAATCAGAGGAAGCACGAGAAGAA
   » Ov17DIII  (100) AAGATGATTTTCATCCATTTGTGCCAAAATCAGAGGAAGCACGAGAAGAA 
   » Ll17DIII  (100) AAGATGATTTTCATCCATTTGTGCCAAAATCAGAGGAAGCACGAGAAGAA
     Contig 1  (100) AAGATGATTTTCATCCATTTGTGCCAAAATCAGAGGAAGCACGAGAAGAA 
                    151                                              200 
   » Bm17DIII  (150) TATTGCGGTTTCTTTAAAGAAATGAATTTGTCCAGAAATGAGTTAATGGA
   » Wb17DIII  (150) TATTGCGGTTTCTTTAAAGAAATGAATTTGTCCAGAAATGAGTTAATGGA 
   » Ov17DIII  (150) TATTGCGGTTTCTTTAAAGAAATGAATTTGTCCAGAAATGAGTTAATGGA
   » Ll17DIII  (150) TATTGCGGTTTCTTTAAAGAAATGAATTTGTCCAGAAATGAGTTAATGGA
     Contig 1  (150) TATTGCGGTTTCTTTAAAGAAATGAATTTGTCCAGAAATGAGTTAATGGA 
                    201                                              250 
   » Bm17DIII  (200) TACAATCAGGAAATGGGCATCAAAATATGGAGTTTTGGAACAATTTGATA
   » Wb17DIII  (200) TACAATCAGGAAATGGGCATCAAAATATGGAGTTTTGGAACAATTTGATA 
   » Ov17DIII  (200) TACAATCAGGAAATGGGCATCAAAATATGGAGTTTTGGAACAATTTGATA
   » Ll17DIII  (200) TACAATCAGGAAATGGGCATCAAAATATGGAGTTTTGGAACAATTTGATA
     Contig 1  (200) TACAATCAGGAAATGGGCATCAAAATATGGAGTTTTGGAACAATTTGATA 
                    251                                              300 
   » Bm17DIII  (250) ACTACGTTGACGAAGAGTTACGATACGAAAATATGGTTTATGATATATTC
   » Wb17DIII  (250) ACTACGTTGACGAAGAGTTACGATACGAAAATATGGTTTATGATATATTC 
   » Ov17DIII  (250) ACTACGTTGACGAAGAGTTACGATACGAAAATATGGTTTATGATATATTC
   » Ll17DIII  (250) ACTACGTTGACGAAGAGTTACGATACGAAAATATGGTTTATGATATATTC
     Contig 1  (250) ACTACGTTGACGAAGAGTTACGATACGAAAATATGGTTTATGATATATTC 
                    301                                              350 
   » Bm17DIII  (300) AAGGATAAAGTTAACAGTACATGTGGGAGTGAAAAAATTAAGAGAACTCT
   » Wb17DIII  (300) AAGGATAAAGTTAACAGTACATGTGGGAGTGAAAAAATTAAGAGAACTCT 
   » Ov17DIII  (300) AAGGATAAAGTTAACAGTACATGTGGGAGTGAAAAAATTAAGAGAACTCT
   » Ll17DIII  (300) AAGGATAAAGTTAACAGTACATGTGGGAGTGAAAAAATTAAGAGAACTCT
     Contig 1  (300) AAGGATAAAGTTAACAGTACATGTGGGAGTGAAAAAATTAAGAGAACTCT 
                    351                                              400 
   » Bm17DIII  (350) TTTCGAAATAACAGATTTGCTAACAGACAGAGATACTGCACAACAAACGA
   » Wb17DIII  (350) TTTCGAAATAACAGATTTGCTAACAGACAGAGATACTGCACAACAAACGA 
   » Ov17DIII  (350) TTTCGAAATAACAGATTTGCTAACAGACAGAGATACTGCACAACAAACGA
   » Ll17DIII  (350) TTTCGAAATAACAGATTTGCTAACAGACAGAGATACTGCACAACAAACGA
     Contig 1  (350) TTTCGAAATAACAGATTTGCTAACAGACAGAGATACTGCACAACAAACGA 
                    401                                              450 
   » Bm17DIII  (400) TTCAGACTAAAATTGATGAAATCATAAATAATTTAAACGAGAGAGAACGG
   » Wb17DIII  (400) TTCAGACTAAAATTGATGAAATCATAAATAATTTAAACGAGAGAGAACGG 
   » Ov17DIII  (400) TTCAGACTAAAATTGATGAAATCATAAATAATTTAAACGAGAGAGAACGG
   » Ll17DIII  (400) TTCAGACTAAAATTGATGAAATCATAAATAATTTAAACGAGAGAGAACGG
     Contig 1  (400) TTCAGACTAAAATTGATGAAATCATAAATAATTTAAACGAGAGAGAACGG 
                    451                                              500 
   » Bm17DIII  (450) ATGGAATTAACTCAATTATGGGCGATACTAGGTGAAGAAGCGATCATCGA
   » Wb17DIII  (450) ATGGAATTAACTCAATTATGGGCGATACTAGGTGAAGAAGCGATCATCGA 
   » Ov17DIII  (450) ATGGAATTAACTCAATTATGGGCGATACTAGGCGAAGAAGCGATCATCGA
   » Ll17DIII  (450) ATGGAATTAACTCAATTATGGGCGATACTAGGCGAAGAAGCGATCATCGA 
     Contig 1  (450) ATGGAATTAACTCAATTATGGGCGATACTAGGYGAAGAAGCGATCATCGA 
                    501                                              550 
   » Bm17DIII  (500) AGCGCAAGACAAATTTGAAAATGGAAATAGTATTTGGGAAGCAGTTGAAA
   » Wb17DIII  (500) AGCGCAAGACAAATTTGAAAATGGAAATAGTATTTGGGAAGCAGTTGAAA 
   » Ov17DIII  (500) AGCGCAAGACAAATTTGAAAATGGAAATAGTATTTGGGAAGCAGTTGAAA
   » Ll17DIII  (500) AGCGCAAGACAAATTTGAAAATGGAAATAGTATTTGGGAAGCAGTTGAAA 
     Contig 1  (500) AGCGCAAGACAAATTTGAAAATGGAAATAGTATTTGGGAAGCAGTTGAAA 
                       
                    551                                              600 
   » Bm17DIII  (550) ATACTACTCAAACTGATAATTTTAAAAGTGAAATAGTAAAAGACAACGAT
   » Wb17DIII  (550) ATACTACTCAAACTGATAATTTTAAAAGTGAAATAGTAAAAGACAACGAT 
   » Ov17DIII  (550) ATACTACTCAAACTGATAATTTTAAAAGTGAAATAGTAAAAGACAACGAT
   » Ll17DIII  (550) ATACTACTCAAACTGATAATTTTAAAAGTGAAATAGTAAAAGACAACGAT
     Contig 1  (550) ATACTACTCAAACTGATAATTTTAAAAGTGAAATAGTAAAAGACAACGAT 
                    601              618 
   » Bm17DIII  (600) AAAATACTAATCAGTAAT
   » Wb17DIII  (600) AAAATACTAATCAGTAAT 
   » Ov17DIII  (600) AAAATACTAATCAGTAAT
   » Ll17DIII  (600) AAAATACTAATCAGTAAT
     Contig 1  (600) AAAATACTAATCAGTAAT 
B
                                                1                                                                                                       50 
     BmR1    (1) MIKMNEKYVKELILLLLFAMIYTSLESNCEFWIEDDFHPFVPKSEEAREE 
Wb-BmR1    (1) MIKMNEKYVKELILLLLFAMIYTSLESNCEFWIEDDFHPFVPKSEEAREE 
Ov-BmR1    (1) MIKMNEKYVKELILLLLFAMIYTSLESNCEFWTEDDFHPFVPKSEEAREE 
Ll-BmR1    (1) MIKMNEKYVKELILLLLFAMIYTSLESNCEFWTEDDFHPFVPKSEEAREE 
              51                                               100 
   BmR1   (50) YCGFFKEMNLSRNELMDTIRKWASKYGVLEQFDNYVDEELRYENMVYDIF 
Wb-BmR1   (50) YCGFFKEMNLSRNELMDTIRKWASKYGVLEQFDNYVDEELRYENMVYDIF 
Ov-BmR1   (50) YCGFFKEMNLSRNELMDTIRKWASKYGVLEQFDNYVDEELRYENMVYDIF 
Ll-BmR1   (50) YCGFFKEMNLSRNELMDTIRKWASKYGVLEQFDNYVDEELRYENMVYDIF 
              100                                              150 
   BmR1  (100) KDKVNSTCGSEKIKRTLFEITDLLTDRDTAQQTIQTKIDEIINNLNERER 
Wb-BmR1  (100) KDKVNSTCGSEKIKRTLFEITDLLTDRDTAQQTIQTKIDEIINNLNERER 
Ov-BmR1  (100) KDKVNSTCGSEKIKRTLFEITDLLTDRDTAQQTIQTKIDEIINNLNERER 
Ll-BmR1  (100) KDKVNSTCGSEKIKRTLFEITDLLTDRDTAQQTIQTKIDEIINNLNERER
              151                                              200 
   BmR1  (150) MELTQLWAILGEEAIIEAQDKFENGNSIWEAVENTTQTDNFKSEIVKDND
Wb-BmR1  (150) MELTQLWAILGEEAIIEAQDKFENGNSIWEAVENTTQTDNFKSEIVKDND 
Ov-BmR1  (150) MELTQLWAILGEEAIIEAQDKFENGNSIWEAVENTTQTDNFKSEIVKDND
Ll-BmR1  (150) MELTQLWAILGEEAIIEAQDKFENGNSIWEAVENTTQTDNFKSEIVKDND 
              201 
   BmR1  (200) KILISN 
Wb-BmR1  (200) KILISN 
Ov-BmR1  (200) KILISN 
Ll-BmR1  (200) KILISN Filaria Journal 2004, 3:10 http://www.filariajournal.com/content/3/1/10
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reactions). The Ov-BmR1 and Ll-BmR1 were 100% identi-
cal to each other, and only two base pairs were different
from BmR1 and Wb-BmR1 i.e. at 97 bp and 483 bp. When
the amino acid sequences were compared only one amino
acid difference was observed: the uncharged polar isoleu-
cine at position 33 was substituted by a neutral threonine
(Figure 1).
Antibody reactivity to BmR1, Ov-BmR1 and Ll-BmR1 
recombinant antigens
For IgG4-ELISA, serum samples that demonstrated aver-
age optical density (OD) readings of ≥0.300 were consid-
ered to be positive [9]. The comparison of IgG4 reactivites
with BmR1 and its homologs (Ov-BmR1 and Ll-BmR1)
using a panel of 201 sera samples from individuals with
various parasitic infections and 61 healthy controls (29
endemic normals and 32 non-endemic normals) indi-
cated that the exchange of one amino acid had no influ-
ence on the reactivity of IgG4 antibodies. The IgG4-ELISA
results showed all recombinant antigens were identical in
reactivity with the various categories of sera (Table 1).
Reactivities of BmR1 and its homologs (Ov-BmR1 and Ll-
BmR1) with serum antibodies of the other three IgG sub-
classes (IgG1, IgG2 and IgG3) using samples from O. vol-
vulus  and  L. loa infected individuals showed positive
reactions with only IgG1. Most IgG1 positive samples had
an OD >1.000. Similarly, the reactivities of anti-filarial
IgG1, IgG2 and IgG3 antibody subclasses with BmR1 on
serum samples from active and chronic cases of W.
Table 1: Comparison among IgG4 reactivities of BmR1, Ov-BmR1 and Ll-BmR1 using a panel of serum samples from patients with 
various parasitic infections and healthy controls (endemic and non-endemic normals). BmR1 is the antigen expressed by Bm17DIII 
DNA sequence; while Ov-BmR1 and Ll-BmR1 are the antigens expressed by the homologs of Bm17DIII DNA sequence in O. volvulus and 
L. loa respectively.
Serum type No Positive by BmR1 (%) Positive by Ov-BmR1 and Ll-BmR1 (%)
O. volvulus, mf positive 70 1 (1.43) 1 (1.43)
L. loa, mf positive 14 6 (42.86) 6 (42.86)
W. bancrofti, mf positive 33 8 (24.24) 8 (24.24)
B. malayi, mf positive 28 28 (100) 28 (100)
Trichuris trichiura 80 0
Ascaris lumbricoides 80 0
Mixed infection with T. trichuris, A. lumbricoides and hookworm 8 0 0
Entamoeba histolytica (invasive) 11 0 0
Toxocara 14 0 0
Gnathostoma spinigerum 10 0
Strongyloides stercoralis 60 0
Endemic normals (healthy controls) 29 0 0
Non-endemic normals (healthy controls) 32 0 0
TOTAL 262
Table 2: Results of ELISAs to detect IgG1, IgG2 and IgG3 anti-filarial antibodies in serum samples from patients with various 
helminthiasis and healthy controls (non-endemic normals) using BmR1, Ov-BmR1 and Ll-BmR1. All antigens (tested separately) 
demonstrated identical results with all serum samples.
Type of serum sample Number of positive results out of number of samples tested
IgG1-ELISA IgG2-ELISA IgG3-ELISA
O. volvulus mf+ 47/47 0/21 0/21
L. loa mf+ 14/14 0/14 0/14
W. bancrofti mf+ 6/6 0/6 0/6
W. bancrofti chronic 6/6 0/6 0/6
B. malayi mf+ 10/10 0/10 0/10
B. malayi chronic 14/14 0/14 0/14
Soil-transmitted helminth infections 10/10 0/10 0/10
Non-endemic normals (healthy controls) 10/10 0/10 0/10Filaria Journal 2004, 3:10 http://www.filariajournal.com/content/3/1/10
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bancrofti  and  B. malayi showed positive reactions only
with IgG1. It is also noted that sera from non-endemic
normals and soil-transmitted infections also showed sim-
ilar reactivities i.e. IgG1 positive and IgG2- & IgG3-nega-
tive (Table 2).
Discussion
BmR1, a recombinant B. malayi antigen of ~30 kDa
expressed by Bm17DIII DNA coding sequence (cds), has
been consistently shown to be a sensitive and specific
antigen for the immunodiagnosis of brugian filariasis in
studies employing either ELISA or immunochromato-
graphic rapid test (Brugia Rapid) formats [9,11-13,15].
When compared with the DNA sequences in GenBank,
Bm17DIII cds exhibited 94% homology with the reported
EST sequence derived from B. malayi microfilaria cDNA
(GenBank AW244981). Southern blot hybridization
assays performed on cDNA libraries of L3, L4, mf, adult
male and adult female B. malayi showed that it is present
in all of the above stages (Rahmah et al., unpublished
data). Bands of the correct molecular weight were
observed in a Western blot of B. malayi mf, adult male and
adult female soluble antigens probed with monopurified
antibody to BmR1 (Rahmah et al., unpublished data).
Multicenter evaluations performed with Brugia Rapid
showed variable reactivity of BmR1 to sera of W. bancrofti-
infected patients. Reactivity to sera from Chennai, India
was 54.5% (12/22); from Indonesia was 70% (14/20) and
from the Cook Islands was 90% (9/10) [12,15]. The wide
variation in the reactivity of the assay in Bancroftian
filariasis in the above three geographical areas prompted
us to undertake the current investigation. The present
study has shown that the homolog in W. bancrofti is iden-
tical to the cDNA of BmR1 – irrespective of the source of
the parasites – whether the mf were isolated from the indi-
viduals whose sera showed positive or negative reactivity
with the Brugia Rapid test. Thus the observed differences
in the reactivity of BmR1 antigen with W. bancrofti sera
collected from different geographical regions does not
appear to be due to genotypic variability between differ-
ent isolates of mf. Further studies are currently underway
to determine if the variability in the expression of the gene
could account for the variability in the Brugia Rapid
results with serum samples collected from W. bancrofti
infected individuals.
PCR experiments were performed on the W. bancrofti
genomic DNA samples to obtain an amplicon with a size
greater than 618 bp (since an intron is expected to be
present in genomic material). However, only one promi-
nent band of 618 bp was obtained (very occasionally a
faint band of >1 kb was observed which was shown later
to be due to unspecific amplification). PCR on W. ban-
crofti genomic DNA to amplify the intron sequence (using
primers based on the Bm17DIII  intron) produced a
sequence that shared ~75% homology to the intron of
Bm17DIII. This is believed to be an amplification on
another part of W. bancrofti genome, since PCR using a
pair of internal primers that flank the possible intron site
produced a PCR product of ~300 bp (a size that is
expected if there was no intron). Conversely, amplifica-
tion of B. malayi genomic material produced two kinds of
amplicons: 618 bp and 1010 bp. The latter was comprised
of an intron (393 bp) and two flanking exons (237 bp and
381 bp), the sequences of which were consistent with B.
malayi data at TIGR website http://www.tigr.org/. Thus at
Universiti Sains Malaysia, genomic DNA of Wb17DIII was
found to be intronless, whereas genomic DNA of
Bm17DIII was shown to have two variants (i.e one with
and one without an intron). These results, though seem-
ingly controversial, were a result of exhaustive efforts with
appropriate PCR controls. Data from other laboratories
will hopefully confirm these results.
Anti-BmR1 IgG4 was detected in 84.6% (44/52) of L. loa
sera but generally not detected in O. volvulus serum sam-
ples [11,16]. Ov-BmR1 and Ll-BmR1 were identical to
each other and 99.7% similar to BmR1 (and to Wb-BmR1)
on the nucleotide level (Figure 1). Ov-BmR1 and Ll-BmR1
were found to display identical reactivity compared to
BmR1 when tested with IgG4-ELISA on a panel of serum
samples (Tables 1 &2). Therefore, the difference of one
amino acid between BmR1 and its homologs (Ov-BmR1
and Ll-BmR1) did not alter their antigenicity. It is interest-
ing to note that although IgG4 has been shown to be ele-
vated in onchocerciasis with assays using other
recombinant antigens [18,19], the IgG4 reactivity to
BmR1 or Ov-BmR1 in O. volvulus was generally negative.
One possible explanation for this is that adult worms
mostly express Ov-BmR1 and the immune response to O.
volvulus is predominantly due to mf [20]. This may explain
the very poor IgG4 response to BmR1 and Ov-BmR1. It is
possible that the uptake of antigen from lymphatic filariae
by antigen presenting cells is significantly different com-
pared to O. volvulus (where adult worms and mf reside
either in sub-dermal nodules or in the skin).
The BmR1, Ov-BmR1 and Ll-BmR1 recombinant antigens
were also used to determine if IgG1, IgG2 or IgG3 anti-
bodies in O. volvulus and L. loa serum samples were reac-
tive with the recombinant proteins. In addition, the three
IgG subclasses were also tested with BmR1 on assays using
sera collected from patients with B. malayi and W. ban-
crofti infections. In all cases only anti-filarial IgG1 was
reactive, while anti-filarial IgG2 and IgG3 assays were con-
sistently negative. It is important to note that IgG1 anti-
bodies to BmR1 and its homologs are unspecific and
without any diagnostic value. The BmR1 antigen obvi-Filaria Journal 2004, 3:10 http://www.filariajournal.com/content/3/1/10
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ously contains widespread epitopes that are recognized by
IgG1 antibodies.
Thus based on the current study, BmR1 and its homologs
in W. bancrofti, O. volvulus and L. loa induce IgG antibody
responses restricted to IgG1 and IgG 4 subclasses only.
Unlike the anti-filarial IgG4 response in B. malayi infec-
tion, the IgG4 response to BmR1 in W. bancrofti and L. loa
was not consistently detected in all infected individuals,
indicating that this recombinant antigen will not be of
much use in the diagnosis of these two filarial infections.
Although IgG1 response to BmR1 was observed in all the
filarial infections tested, it lacks specificity since it was also
positive when tested with serum samples from normal
individuals and with those infected with other parasites.
Conclusions
The study demonstrates the presence of identical and
almost identical homologs of the diagnostic BmR1 anti-
gen in other filarial parasites. However, they do not seem
to induce consistent antibody responses in all infected
subjects. Thus the immunogenicity of BmR1 in brugian
filariasis appears to be clearly different from that of ban-
croftian filariasis, onchocerciasis and loiasis.
Competing interests
The author(s) declare that they have no competing
interests.
Authors' contributions
RN – was the principle researcher, designed the study,
supervised the experiments and result analysis, wrote the
first draft of the manuscript.
RAAA – performed the experiments and participated in
the analysis of the data.
BR – provided parasite materials, collected patients' sera,
edited the paper.
Acknowledgements
These studies received financial support from Malaysian Government IRPA 
grant no 06-02-05-1007PR0016/06-05 and European Commission (EC) 
grant, No. ICA4-CT-2001-10081. We would also like to thank Dr. Peter 
Fischer from Bernhard Notch Institute for Tropical Medicine, Hamburg, 
Germany for providing the parasite material, sera samples and helpful 
comments.
References
1. Chandrashekar R, Yates JA, Weil GJ: Use of parasite antigen
detection to monitor macrofilaricidal therapy in Brugia
malayi-infected jirds. J Parasitol 1990, 76:122-124.
2. Ottesen EA, Skvaril LF, Tripathy S, Poindexter RW, Hussain R:
Prominence of IgG4 in the IgG response to human filariasis.
J Immunol 1985, 134:2707-2712.
3. Kwan-Lim GE, Forsyth KP, Maizels RM: Filarial-specific IgG4
responses correlates with active Wuchereria  infection.  J
Immunol 1990, 145:4298-4305.
4. Kurniawan A, Yazdanbakhsh M, van Ree R, Aaberse R, Selkirk ME,
Partono F, Maizels RM: Differential expression of IgE and IgG4-
specific antibody responses in asymptomatic and chronic
human filariasis. J Immunol 1993, 150:3941-3950.
5. Haarbrink M, Terhell A, Abadi K, van Beers S, Asri M, de Medeiros F,
Yazdanbakhsh M: Anti-filarial IgG4 in men and women living in
Brugia malayi endemic areas.  Trop Med Int Health 1999,
4(2):93-97.
6. Wamae CN, Roberts JM, Eberhard ML, Lammie PJ: Kinetics of cir-
culating IgG4 after diethylcarbamazine and ivermectin
treatment of bancrotian filariasis.  J Infect Dis 1992,
165:1158-1160.
7. Kurniawan A, Atkinson R, Sartono E, Partono F, Yazdanbakhsh M,
Maizels RM: Differential decline in filarial specific IgG1, IgG4
and IgE antibodies in Brugia malayi infected patients after
diethylcarbamazine therapy. J Infect Dis 1995, 172:1567-1572.
8. McCarthy JS, Guinea A, Weil GJ, Ottesen EA: Clearance of circu-
lating filarial antigen as a measure of the macrofilaricidal
activity of diethylcarbamazine in Wuchereria bancrofti infec-
tion. J Infect Dis 1995, 172:521-526.
9. Rahmah N, Lim BH, Khairul Anuar A, Shenoy RK, Kumaraswami V,
Lokman Hakim S, Chotechuang P, Kanjanopas K, Ramachandran CP:
A recombinant antigen-based IgG4 ELISA for the specific
and sensitive detection of Brugia malayi detection. Trans R Soc
Trop Med Hyg 2001, 95(3):280-284.
10. Supali T, Rahmah N, Djuardi T, Sartono E, Ruckert P, Fischer P:
Detection of IgG4 antibodies using Brugia Rapid test in indi-
viduals from an area highly endemic for Brugia timori. Acta
Tropica 2004, 90(3):255-261.
11. Rahmah N, Shenoy RK, Nutman TB, Weiss N, Gilmour K, Maizels
RM, Yazdanbakhsh M, Sartono E: Multicenter laboratory evalua-
tion of Brugia Rapid dipstick test for detection of brugian
filariasis. Trop Med Int Health 2003, 8(10):895-900.
12. Rahmah N, Supali T, Shenoy RK, Lim BH, Kumaraswami V, Khairul
Anuar A, Lokman Hakim S, Noor Hayati MI, Chan BT, Suharni M,
Ramachandran CP: Specificity and sensitivity of a rapid dipstick
test (Brugia Rapid) in the detection of Brugia malayi infec-
tion. Trans R Soc Trop Med Hyg 2001, 95:601-604.
13. Lim BH, Rahmah N, Afifi SAB, Ramli A, Mehdi R: Comparison of
Brugia-ELISA and thick blood smear examination in a preva-
lence study of brugian filariasis in Setiu, Terengganu,
Malaysia. Med J Malaysia 2001, 56:491-496.
14. Jamail M, Andrew K, Junaidi D, Krishnan AK, Faizal M, Rahmah N:
Field validation of sensitivity and specificity of a rapid test for
detection of Brugia malayi infection.  in press.
15. Rahmah N, Lim BH, Azian H, Tengku Ramelah TS, Rohana AR: Short
communication: Use of a recombinant antigen-based ELISA
to determine prevalence of brugian filariasis among Malay-
sian School children near Pasir Mas, Kelantan – Thailand
border. Trop Med Int Health 2003, 8:158-163.
16. Fischer P, Bonow I, Supali T, Ruckert P, Rahmah N: Combination of
serological and PCR-based assays for screening of blood
spots to detect Brugia timori infections.  in press.
17. Fischer P, Kipp W, Bamuhiga J, Binta-Kahwa J, Kiefer A, Buttner DW:
Parasitological and clinical characterization of Simulium
neavei-transmitted onchocerciasis in western Uganda. Trop
Med Parasitol 1993, 44:311-321.
18. Lucius R, Kern A, Seeber F, Pogonka T, Willenbucher J, Taylor HR,
Pinder M, Ghalib HW, Schulz-Key H, Soboslay P: Specific and sen-
sitive IgG4 immunodiagnosis of onchocerciasis with recom-
binant 33 kD Onchocerca volvulus protein (Ov33). Trop Med
Parasitol 1992, 43:139-143.
19. Chandrashekar R, Ogunrinad AF, Weil GJ: Use of a recombinant
Onchocerca volvulus antigens for diagnosis and surveillance of
human onchocerciasis. Trop Med Int Health 1996, 1:575-580.
20. Kazura JW, Nutman TB, Greene BM: Filariasis. In In Immunology and
molecular biology of parasitic infections 3rd edition. Edited by: Warren
KS. Blackwell Scientific Publications, Oxford; 1993:473-495. 